These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9492245)

  • 1. Remission of cancer chemotherapy-induced emesis during antidepressant therapy with nefazodone.
    Khouzam HR; Monteiro AJ; Gerken ME
    Psychosom Med; 1998; 60(1):89-91. PubMed ID: 9492245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New antidepressant drugs and the treatment of depression in the medically ill patient.
    Stoudemire A
    Psychiatr Clin North Am; 1996 Sep; 19(3):495-514. PubMed ID: 8856814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.
    Elliott AJ; Russo J; Bergam K; Claypoole K; Uldall KK; Roy-Byrne PP
    J Clin Psychiatry; 1999 Apr; 60(4):226-31. PubMed ID: 10221282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
    Sussman N; Ginsberg DL; Bikoff J
    J Clin Psychiatry; 2001 Apr; 62(4):256-60. PubMed ID: 11379839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of SSRI-induced akathisia after switch to nefazodone.
    Chelben J; Strous RD; Lustig M; Baruch Y
    J Clin Psychiatry; 2001 Jul; 62(7):570-1. PubMed ID: 11488371
    [No Abstract]   [Full Text] [Related]  

  • 6. A case report of serotonin syndrome associated with combined nefazodone and fluoxetine.
    Smith DL; Wenegrat BG
    J Clin Psychiatry; 2000 Feb; 61(2):146. PubMed ID: 10732666
    [No Abstract]   [Full Text] [Related]  

  • 7. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG; Cold JA; Jann MW
    Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of the new antidepressants.
    Nelson JC
    J Clin Psychiatry; 1997; 58 Suppl 6():26-31. PubMed ID: 9227670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probable nefazodone-induced mania in a patient with unreported bipolar disorder.
    Zaphiris HA; Blaisdell GD; Jermain DM
    Ann Clin Psychiatry; 1996 Dec; 8(4):207-10. PubMed ID: 8986316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertraline-induced anorgasmia treated with intermittent nefazodone.
    Reynolds RD
    J Clin Psychiatry; 1997 Feb; 58(2):89. PubMed ID: 9062383
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacology of antidepressants: focus on nefazodone.
    DeVane CL; Grothe DR; Smith SL
    J Clin Psychiatry; 2002; 63 Suppl 1():10-7. PubMed ID: 11890560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Applications and safety of modern antidepressants in patients with liver diseases].
    Dubarek W; Kucia K
    Wiad Lek; 2007; 60(1-2):28-33. PubMed ID: 17607965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use of nefazodone in major depression: a 6-year perspective.
    Schatzberg AF; Prather MR; Keller MB; Rush AJ; Laird LK; Wright CW
    J Clin Psychiatry; 2002; 63 Suppl 1():18-31. PubMed ID: 11890561
    [No Abstract]   [Full Text] [Related]  

  • 14. Nefazodone withdrawal symptoms.
    Benazzi F
    Can J Psychiatry; 1998 Mar; 43(2):194-5. PubMed ID: 9533975
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to nefazodone in a depressed patient with end-stage renal disease.
    Seabolt JL; De León OA
    Gen Hosp Psychiatry; 2001; 23(1):45-6. PubMed ID: 11291641
    [No Abstract]   [Full Text] [Related]  

  • 16. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.
    Feiger A; Kiev A; Shrivastava RK; Wisselink PG; Wilcox CS
    J Clin Psychiatry; 1996; 57 Suppl 2():53-62. PubMed ID: 8626364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive nefazodone in neuroleptic-treated schizophrenic patients with predominantly negative symptoms: an open prospective pilot study.
    Joffe G; Appelberg B; Rimón R
    Int Clin Psychopharmacol; 1999 Jul; 14(4):233-8. PubMed ID: 10468316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: comparing patients who recently discontinued an SSRI with those on no recent antidepressant treatment.
    Mischoulon D; Opitz G; Kelly K; Fava M; Rosenbaum JF
    Depress Anxiety; 2004; 19(1):43-50. PubMed ID: 14978785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of chemotherapy-induced emesis with concurrent olanzapine treatment: a case report.
    Pirl WF; Roth AJ
    Psychooncology; 2000; 9(1):84-7. PubMed ID: 10668063
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.
    Rush AJ; Armitage R; Gillin JC; Yonkers KA; Winokur A; Moldofsky H; Vogel GW; Kaplita SB; Fleming JB; Montplaisir J; Erman MK; Albala BJ; McQuade RD
    Biol Psychiatry; 1998 Jul; 44(1):3-14. PubMed ID: 9646878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.